Eco-Friendly Simultaneous Chromatographic Determination of Amiloride Hydrochloride, Atenolol, and Hydrochlorothiazide in Urine

• Autorzy: Albishri H. M. , El-Hady D. , Tayeb R. A.
• Języki publikacji: EN

Abstrakty

EN

Pharmaceutical industry concerned recently with eco-friendly analytical methods to reduce the environmental pollution. The using of toxic organic solvents for the analysis of drugs is critical. In the current work, several simple and less costly approaches such as micellar and/or cyclodextrin liquid chromatography were discussed. A new eco-friendly and simple chromatographic analysis of the ternary mixture of amiloride hydrochloride (AM), atenolol (AT), and hydrochlorothiazide (HZ) in urine by hydroxypropyl-beta-cyclodextrin (HP-β-CD) bonded stationary phase was investigated. The experimental conditions were optimized and validated based on International Conference on Harmonization (ICH) Q2R1 guidelines to detect analytes by isocratic mobile phase of phosphate buffer (5.0 mmol L^-1, pH 7.0) in the presence of 0.5 mL min^-1 flow rate, 25.0 °C, and 280 nm. Linearity, accuracy, and precision were found to be acceptable over the concentration range of 0.05–20.0 μg Ml^-1 for AM, 0.05–50.0 μg Ml^-1 for AT and 0.05–50.0 μg Ml^-1 for HZ. The proposed method was precise, selective, and sensitive enough for the routine analysis of ternary mixture at therapeutic urine levels. The inclusion complexation and the appendant hydroxyl groups of HP-β-CD were considered the main reasons for assisting in adequate separation of the drugs. On the other hand, the presence of kosmotropic phosphate ions could solubilize the protein and could strengthen the selective inclusion of drugs inside HP-β-CD cavity. Urinary excretion studies showed that the detection of drugs is possible up to 24 h after their ingestion.

Słowa kluczowe

EN

liquid chromatography; cyclodextrin; amiloride; atenolol; hydrochlorothiazide

• Wydawca: University of Silesia in Katowice ; Akademiai Kiado
• Czasopismo: Acta Chromatographica
• Rocznik: 2015
• Tom: Vol. 27, no. 3
• Strony: 461--476
• Opis fizyczny: Bibliogr. 35 poz., rys., tab.

Twórcy

autor

Albishri H. M.

• Chemistry Department, Faculty of Science, King Abdulaziz University, Saudi Arabia

autor

El-Hady D.

• Chemistry Department, Faculty of Science-North Jeddah, King Abdulaziz University, Saudi Arabia
• Chemistry Department, Faculty of Science, Assiut University, 71516-Assiut, Egypt

autor

Tayeb R. A.

• Chemistry Department, Faculty of Science, King Abdulaziz University, Saudi Arabia

Bibliografia

• [1] J.L. Tucker. Org. Process Res. Dev., 10(2), 315 (2006)
• [2] N.G. Anderson. In: D.S. Johnson and J.J. Li (Eds) Art of Drug Synthesis, John Wiley & Sons, Hobooken, New Jersey, 2007, pp. 1128
• [3] C. Jimenez-Gonzalez, A.D. Curzons, D.J.C. Constable, and V.L. Cunningham. Int. J. Life Cycle Assess., 9, 114 (2004)
• [4] A.D. Curzons, C. Jimenez-Gonzalez, A.L. Duncan, D.J.C. Constable, and V.L. Cunningham. Int. J. Life Cycle Assess., 12, 272 (2007)
• [5] P. Anastas and J. Warner (Eds) Green Chemistry: Theory and Practice, Oxford University Press, Oxford, UK, 1998
• [6] B.W. Cue and J. Zhang. Green Chem. Lett. Rev., 2, 193 (2009)
• [7] K. Richter, R. Oertel, and W. Kirch. J. Chromatogr. A, 729, 293 (1996)
• [8] L. Corea, M. Bentivoglio, and P. Verdecchia. Int. J. Clin. Pharmacol. Res., 3, 367 (1983)
• [9] R.R. Shawahna. Daru, J. Pharm. Sci., 19 (2011)
• [10] A.M. Albishri. Chromatographia, 75, 1327 (2012)
• [11] G. Huang, R.M. Smith, H.M. Albishri, and J.-M. Lin. Chromatographia, 72, 1177 (2010)
• [12] Y.J. Park, D.W. Lee, and W.Y. Lee. Anal. Chim. Acta, 471, 51 (2002)
• [13] R. Ceresole, M.A. Moyano, M.T. Pizzorno, and A.I. Segall. J. Liq. Chromatogr. Relat. Technol., 29, 3009 (2006)
• [14] G. Venkatesh, S. Ramanathan, S.M. Mansor, N.K. Nair, M. Abdul Sattar, S.L. Croft, and V. Navaratnam. J. Pharm. Biomed. Anal.,, 43, 1546 (2007)
• [15] V.P. Ranta, E. Toropainen, A. Talvitie, S. Auriola, and A. Urtti. J. Chromatogr. B, 772, 81 (2002)
• [16] A. El Gindy, S. Sallam, and R.A. Abdel Salam. J. Sep. Sci., 31, 677 (2008)
• [17] V.P. Rane, J.N. Sangshetti, and D.B. Shinde. J. Chromatogr. Sci., 46, 887 (2008)
• [18] S. Shaikh, O.A. Thusleem, M.S. Muneera, J. Akmal, A.V. Kondaguli, and K. Ruckmani. J. Pharm. Biomed. Anal., 48, 1055 (2008)
• [19] S.J. Joshi, P.A. Karbhari, S.I. Bhoir, K.S. Bindu, and C. Das. J. Pharm. Biomed. Anal., 52, 362 (2010)
• [20] M.A. Obando, J.M. Estela, and V. Cerdà. Anal. Bioanal. Chem., 391, 2349 (2008)
• [21] H. Li, Y. Wang, Y. Jiang, Y. Tang, J. Wang, L. Zhao, and J. Gu. J. Chromatogr. B, 852, 436 (2007)
• [22] M.P. Tagliari, H.K. Stulzer, F.S. Murakami, G. Kuminek, B. Valente, P.R. Oliveira, and M.A.S. Silva. Chromatographia, 67, 647 (2008)
• [23] A.A. Elshanawane, S.M. Mostafa, and M.S. Elgawish. J. AOAC Int., 92, 404 (2009)
• [24] R.I. El-Bagary, E.F. Elkady, and A.J. Faqeh. J. Chem. Pharm. Res., 3, 320 (2011)
• [25] G.J. Murray and J.P. Danaceau. J. Chromatogr. B, 877, 3857 (2009)
• [26] S. Marco-Peiro, B. Beltrin-Martinavarro, M. Rambla-Alegre, J. Peris-Vicente, and J. Esteve-Romero. Talanta, 88, 617 (2012)
• [27] V. Gonzalez-Ruiz, A.G. Leon, A.I. Olives, M. Antonia Martin, and J. Carlos Menendez. Green Chem., 13, 115 (2011)
• [28] S. Carda-Broch, I. Rapado-Martínez, J. Esteve-Romero, and M.C. García-Alvarez-Coque. J. Chromatogr. Sci., 37, 93 (1999)
• [29] M. Rambla-Alegre, M.T. Gil-Agusti, M.E. Capella-Peiro, S. Carda-Broch, and J. Esteve-Romero. J. Chromatogr. B, 839, 89 (2006)
• [30] D. Chen, S. Jiang, Y. Chen, and Y. Hu. J. Pharm. Biomed. Anal., 34, 239 (2004)
• [31] D. Abd El-Hady and N. Abo El-Maali. Talanta, 76, 138 (2008)
• [32] R. Gotti, D. Abd El-Hady, V. Andrisano, C. Bertucci, N. Abo El-Maali, and V. Cavrini. Electrophoresis, 25, 2830 (2004)
• [33] International Conference on Harmonisation of Technical of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R1). Complementary Guideline on Methodology Dated, 1996. Incorporated in November 2005, London. http://www.ich.org/LOB/media/MEDIA417.pdf
• [34] European Medicines Agency (EMEA), Guidline on Bioanalytical Method Validation, 2011. http://www.tga.gov.au/pdf/euguide/ewp1922172009.pdf
• [35] U.S. Department of Health and Human Services, Food and Drug Administration, Guidance for Industry, Bioanalytical Method Validation, revision 1, 2013. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInforma tion/Guidances/UCM368107.pdf